Literature DB >> 20354682

Autocrine/paracrine action of vitamin D on FGF23 expression in cultured rat osteoblasts.

Wen-Jing Tang1, Li-Fang Wang, Xiao-Ya Xu, Yi Zhou, Wei-Fang Jin, Hong-Fu Wang, Jianjun Gao.   

Abstract

To explore the local mechanisms of fibroblast growth factor (FGF) 23 regulations, we examined the FGF23 expression patterns in an osteoblast culture model. The characteristics of cultured rat calvaria osteoblasts in half-confluence, confluence, osteoid deposition, and osteoid mineralization stages might reflect the proliferation, differentiation, maturation, and matrix mineralization stages, respectively. Compared with proliferating cells in half-confluence, FGF23 expression was upregulated by 7.5-fold at the mRNA level and 126% at the protein level in confluent differentiated cells as determined by real-time RT-PCR and Western blot analysis. Interestingly, mRNA levels of CYP27B1 (the gene coding for 1alpha-hydroxylase enzyme which catalyses the conversion of 1alpha,25-dihydroxyvitamin D, 1alpha,25[OH]2D, from its inactive form, 25-hydroxycholecalciferol, 25[OH]D) and CYP24A (the gene coding for 24-hydroxylase, a target gene of 1alpha,25[OH]2D) were significantly increased by twofold and 34-fold, respectively, in differentiated osteoblasts compared with proliferating cells. We next examined if the local production of 1alpha,25(OH)2D might contribute to the FGF23 upregulation. We cultured osteoblasts in serum-free medium with or without 25-(OH)D (the substrate of 1alpha-hydroxylase). FGF23 mRNA levels were increased in proliferating cells (16-fold) and in differentiated cells (28-fold) by the physiological dose of 25-(OH)D3 treatment. CYP27B1 was slightly but significantly upregulated and CYP24A was increased by 1,700-fold and 800-fold, respectively, in transcriptional levels. Because FGF23 was upregulated in confluent osteoblasts regardless of the presence or absence of 25-(OH)D in serum-free medium, we further examined the possible impact of cell communication on FGF23 expression. We treated osteoblasts with carbenoxolone, a gap junction Cx43 blocker in serum-free medium. The FGF23 mRNA level was reduced by 50% in confluent differentiated cells and slightly but not significantly reduced in half-confluent cells by carbenoxolone treatments. The results suggested that upregulation of FGF23 in differentiated osteoblast appeared to be due to increased autocrine/paracrine action of osteoblast-derived 1alpha,25(OH)2D and increased cell communication, which were identified in cultured rat calvaria osteoblasts. These results indicate that FGF23 expression was stimulated not only by circulating calcitriol but also by locally produced 1alpha,25(OH)2D. The local mechanisms of FGF23 expression remain to be characterized.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20354682     DOI: 10.1007/s00223-010-9355-2

Source DB:  PubMed          Journal:  Calcif Tissue Int        ISSN: 0171-967X            Impact factor:   4.333


  18 in total

Review 1.  Fibroblast growth factors: from molecular evolution to roles in development, metabolism and disease.

Authors:  Nobuyuki Itoh; David M Ornitz
Journal:  J Biochem       Date:  2010-10-12       Impact factor: 3.387

Review 2.  Steroid Hormone Vitamin D: Implications for Cardiovascular Disease.

Authors:  Linda L Demer; Jeffrey J Hsu; Yin Tintut
Journal:  Circ Res       Date:  2018-05-25       Impact factor: 17.367

3.  A typical RNA-binding protein gene (AccRBM11) in Apis cerana cerana: characterization of AccRBM11 and its possible involvement in development and stress responses.

Authors:  Guilin Li; Haihong Jia; Hongfang Wang; Yan Yan; Xingqi Guo; Qinghua Sun; Baohua Xu
Journal:  Cell Stress Chaperones       Date:  2016-09-02       Impact factor: 3.667

4.  Autocrine and paracrine actions of vitamin d.

Authors:  Howard A Morris; Paul H Anderson
Journal:  Clin Biochem Rev       Date:  2010-11

Review 5.  Cutaneous skeletal hypophosphatemia syndrome (CSHS) is a multilineage somatic mosaic RASopathy.

Authors:  Young H Lim; Diana Ovejero; Kristina M Derrick; Michael T Collins; Keith A Choate
Journal:  J Am Acad Dermatol       Date:  2016-08       Impact factor: 11.527

6.  NFκB-sensitive Orai1 expression in the regulation of FGF23 release.

Authors:  Bingbing Zhang; Jing Yan; Anja T Umbach; Hajar Fakhri; Abul Fajol; Sebastian Schmidt; Madhuri S Salker; Hong Chen; Dorothea Alexander; Daniela Spichtig; Arezoo Daryadel; Carsten A Wagner; Michael Föller; Florian Lang
Journal:  J Mol Med (Berl)       Date:  2015-12-03       Impact factor: 4.599

7.  Fibroblast growth factor 23 enhances renal klotho abundance.

Authors:  Tsuneo Takenaka; Yusuke Watanabe; Tsutomu Inoue; Takashi Miyazaki; Hiromichi Suzuki
Journal:  Pflugers Arch       Date:  2013-03-07       Impact factor: 3.657

8.  Parathyroid hormone receptor signaling in osteocytes increases the expression of fibroblast growth factor-23 in vitro and in vivo.

Authors:  Yumie Rhee; Nicoletta Bivi; Emily Farrow; Virginia Lezcano; Lilian I Plotkin; Kenneth E White; Teresita Bellido
Journal:  Bone       Date:  2011-06-25       Impact factor: 4.398

Review 9.  Experimental evidence for the effects of calcium and vitamin D on bone: a review.

Authors:  Howard A Morris; Peter D O'Loughlin; Paul H Anderson
Journal:  Nutrients       Date:  2010-09-17       Impact factor: 5.717

10.  Paricalcitol versus cinacalcet plus low-dose vitamin D for the treatment of secondary hyperparathyroidism in patients receiving haemodialysis: study design and baseline characteristics of the IMPACT SHPT study.

Authors:  Markus Ketteler; Kevin J Martin; Mario Cozzolino; David Goldsmith; Amit Sharma; Samina Khan; Emily Dumas; Michael Amdahl; Steven Marx; Paul Audhya
Journal:  Nephrol Dial Transplant       Date:  2011-09-19       Impact factor: 5.992

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.